Back to Medicine Index

Mixtard 30 100 IU/ml

Injection

Generic: Insulin Human Premixed 30/70 (Soluble 30% + Isophane 70%)

Novo Nordisk Pharma (Pvt.) Ltd.

Therapeutic Class: Premixed (Biphasic) Insulin

Indications

Diabetes mellitus requiring insulin, where both a rapid initial effect and a prolonged effect are needed.

Pharmacology

This is a mixture of 30% soluble human insulin and 70% isophane (NPH) human insulin. The soluble part acts within about 30 minutes and the isophane part gives a prolonged effect, so the total duration of action is up to about 24 hours.

Dosage & Administration

The dose is individual and is decided by the physician; usually given once or twice daily. Inject under the skin about 30 minutes before a meal; rotate the injection site. Gently mix the suspension before each use. Never give intravenously.

Side Effects

Hypoglycaemia (sweating, tremor, hunger, palpitations, confusion), weight gain, redness or swelling at the injection site, and lumps or hollows under the skin (lipodystrophy). Allergic reactions are rare.

Precautions & Warnings

Monitor blood glucose regularly and do not skip the meal after the injection. The dose may need adjustment with illness, change of diet or exercise, and in renal or hepatic impairment. Use a syringe that matches the strength of the vial (40 IU/ml or 100 IU/ml).

Contraindications

Hypoglycaemia, intravenous use, and hypersensitivity to human insulin or any ingredient of the preparation.

Storage Conditions

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light and heat. After first use follow the pack leaflet for the in-use period. Keep out of the reach of children.

This information is for reference only. Always consult a qualified doctor or pharmacist before taking any medicine.

Other brands of the same generic